SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

SHILPA MEDICARE

BSE: 530549 29 Jun 2025
Healthcare
₹ 880
Shilpa Medicare Ltd. specializes in Pharmaceuticals within the Healthcare sector.

SHILPA MEDICARE - Share Price & Details

Market Cap
₹8,449
High /Low
1,003 / 530.0
Stock P/E
94.4
Book Value
₹243.0
Dividend Yield
0.0
ROCE
7.94
ROE
₹4.28
Face Value
1.0
PEG Ratio
-9.13
EVEBITDA
₹26.6
Debt
588
CMP / FCF
-152.0
Debt to equity
₹0.25
NP Ann
78.3
High price all time
1,003
Piotroski score
₹7.0
Graham Number
209.0
No. Eq. Shares
9.78
Net CF
₹-4.25
Net profit
78.3
Price to book value
3.56
Interest Coverage
₹2.99
Low price all time
4.33
Industry PE
32.7
Reserves
₹2,362
Free Cash Flow
₹-83.9

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
SHILPA MEDICARE LTD.NANANANA8,44994.4
STRIDES PHARMA SCIENCE LIMITED5680.8161.285559.581.75828323.4
FDC LTD.NANANANA780929.3

Peer Comparison Chart


About SHILPA MEDICARE

Shilpa Medicare Ltd., with Security Code 530549, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Shilpa Medicare gains on launching QIP; floor price at Rs 477.33/share

(15 Jun 2025)
The pharma company's board authorized and declared the opening of the issue on Monday, 8 April 2024. The floor price of Rs 477.33 is at a disco...
Read more →

Shilpa Medicare Barred from FDA Approval of Lenvatinib Mesylate Generic Until February 2036

(14 Jun 2025)
A recent legal decision has determined that Shilpa Medicare Limited will not be eligible to receive FDA approval for its generic version of...
Read more →

Why is Shilpa Medicare falling/rising?

(12 Jun 2025)
As of 11-Jun, Shilpa Medicare Ltd's stock price is at Rs. 974.75, having risen 2.61% and reached a new all-time high of Rs. 980. Despite strong short-term...
Read more →

Shilpa Medicare Barred from FDA Approval for Generic Lenvatinib Mesylate Until February 2036 Following Patent Dispute

(11 Jun 2025)
A recent legal judgment has determined that Shilpa Medicare Limited will not be eligible to receive FDA approval for its generic version of lenvatinib...
Read more →

SHILPA MEDICARE ANNOUNCES BOARD MEETING DATE

(10 Jun 2025)
Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 8 February 2024.
Read more →

Shilpa Medicare Share Price

(05 Jun 2025)
What's Shilpa Medicare Ltd share price today. Get Shilpa Medicare Ltd latest news on BSE/NSE stock price live updates, Shilpa Medicare Ltd...
Read more →